Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus

Metformin is an oral hypoglycemic agent widely used in clinical practice for treatment of patients with type 2 diabetes mellitus (T2DM). The wide interindividual variability of response to metformin therapy was shown, and recently the impact of several genetic variants was reported. To assess the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasykhova, Yulia A., Barbitoff, Yury A., Tonyan, Ziravard N., Danilova, Maria M., Nevzorov, Ivan A., Komandresova, Tatiana M., Mikhailova, Anastasiia A., Vasilieva, Tatiana V., Glavnova, Olga B., Yarmolinskaya, Maria I., Sluchanko, Evgenia I., Glotov, Andrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330240/
https://www.ncbi.nlm.nih.gov/pubmed/35893047
http://dx.doi.org/10.3390/genes13081310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330240/
https://www.ncbi.nlm.nih.gov/pubmed/35893047
http://dx.doi.org/10.3390/genes13081310

Ejemplares similares